[ET Net News Agency, 18 February 2021] Sinopharm Tech Holdings Limited (08156) said its
subsidiary China Success Enterprises Limited has agreed to buy 25% of the issued share
capital of the target company upon completion of the reorganisation at the consideration
of HK$200 million.
The consideration will be settled by allotment and issue of the consideration shares at
the issue price of HK$0.28 per consideration share. The consideration shares represent
approximately 14.27% of the issued share capital of the company as enlarged.
The target company is Rich General Limited. It will hold the entire issued share capital
of the HKCo and in turn the SZCo immediately upon completion of the reorganisation. The
SZCo is the registered holder of the patents and is engaged in the business of provision
of services in relation to the design, development and provision of anti-counterfeiting
devices in the PRC. (RC)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08156 SINOPHARM TECH
Nominal 
0.100 0.000 (0.000%) Others
18/02/2021 15:24
Sinopharm Tech (08156) to buy 25% of company at HK$200m
| Remark: | Real time quote last updated: 19/04/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |